Covering all the issues affecting the CCA market, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report spans 10 in-depth country profiles (plus shorter profiles of selected markets) with insights and predictions.
With launch activity in CCA slowing, has the impetus shifted from quantity to quality? New product developments are explored across markets, including Rx-to-OTC switches, delivery format innovations, new benefits and more.
Brand case studies evaluate the key lessons to be learned from top brands, including consumer messaging, line extensions, portfolio development and brand strategies.
The report features the latest sales data from our dedicated DB6 database, including topline historical sales by region, country and category, and individual brand performances.
Table of Contents
Executive Summary
- Global CCA overview
- Systemic cold & flu
- Cough remedies
- Sore throat remedies & medicated confectionery
- Topical decongestants
- Systemic decongestants
- Chest rubs & inhalants
- Allergy remedies
- Immune supplements
- Outlook, forecasts & opportunities
Australia
- Overview
- Regulations & classifications
- Impact of Covid
- Systemic cold & flu
- Cough remedies
- Sore throat remedies & medicated confectionery
- Topical decongestants
- Systemic decongestants
- Chest rubs & inhalants
- Allergy remedies
- Immune supplements
- Outlook, forecasts & opportunities
Brazil
- Overview
- Regulations & classifications
- Impact of Covid
- Systemic cold & flu
- Cough remedies
- Sore throat remedies & medicated confectionery
- Topical decongestants
- Systemic decongestants
- Chest rubs & inhalants
- Allergy remedies
- Immune supplements
- Outlook, forecasts & opportunities
China
- Overview
- Regulations & classifications
- Impact of Covid
- Systemic cold & flu
- Cough remedies
- Sore throat remedies & medicated confectionery
- Topical decongestants
- Systemic decongestants
- Chest rubs & inhalants
- Allergy remedies
- Immune supplements
- Outlook, forecasts & opportunities
France
- Overview
- Regulations & classifications
- Impact of Covid
- Systemic cold & flu
- Cough remedies
- Sore throat remedies & medicated confectionery
- Topical decongestants
- Chest rubs & inhalants
- Allergy remedies
- Immune supplements
- Outlook, forecasts & opportunities
Germany
- Overview
- Regulations & classifications
- Impact of Covid
- Systemic cold & flu
- Cough remedies
- Sore throat remedies & medicated confectionery
- Topical decongestants
- Systemic decongestants
- Chest rubs & inhalants
- Allergy remedies
- Immune supplements
- Outlook, forecasts & opportunities
India
- Overview
- Regulations & classifications
- Impact of Covid
- Systemic cold & flu
- Cough remedies
- Sore throat remedies & medicated confectionery
- Topical decongestants
- Chest rubs & inhalants
- Allergy remedies
- Immune supplements
- Outlook, forecasts & opportunities
Italy
- Overview
- Regulations & classifications
- Impact of Covid
- Systemic cold & flu
- Cough remedies
- Sore throat remedies & medicated confectionery
- Topical decongestants
- Systemic decongestants
- Allergy remedies
- Immune supplements
- Outlook, forecasts & opportunities
Japan
- Overview
- Regulations & classifications
- Impact of Covid
- Systemic cold & flu
- Cough remedies
- Sore throat remedies & medicated confectionery
- Topical decongestants
- Allergy remedies
- Outlook, forecasts & opportunities
Poland
- Overview
- Regulations & classifications
- Impact of Covid
- Systemic cold & flu
- Cough remedies
- Sore throat remedies & medicated confectionery
- Topical decongestants
- Systemic decongestants
- Allergy remedies
- Immune supplements
- Outlook, forecasts & opportunities
USA
- Overview
- Regulations & classifications
- Impact of Covid
- Systemic cold & flu
- Cough remedies
- Sore throat remedies & medicated confectionery
- Topical decongestants
- Systemic decongestants
- Chest rubs & inhalants
- Allergy remedies
- Asthma remedies
- Immune supplements
- Outlook, forecasts & opportunities
Selected Markets in Brief
Brand Case Studies
- Bisolvon / Mucosolvan
- Claritin
- Flonase
- Robitussin
- Xyzal
Outlook
- An altered world
- Short-term CCA market forecast
- Long-term CCA market forecast
- Prospects for immunity
- A thriving online channel